ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

SAGE Sage Therapeutics Inc

13.71
0.605 (4.62%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sage Therapeutics Inc SAGE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.605 4.62% 13.71 13:00:08
개장가 저가 고가 종가 전일 종가
13.46 13.45 13.97 13.94 13.105
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202419:30BWSage Therapeutics Announces First Quarter 2024 Financial..
17/04/202419:30BWSage Therapeutics Announces Topline Results from Phase 2..
11/04/202419:30BWSage Therapeutics to Report First Quarter 2024 Financial..
28/02/202420:30BWSage Therapeutics to Present at Upcoming March Investor..
22/02/202406:35EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
16/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:09EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/02/202421:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/02/202421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/02/202420:45EDGAR2Form 8-K - Current report
14/02/202420:30BWSage Therapeutics Announces Fourth Quarter and Full Year..
01/02/202407:25EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
01/02/202406:50EDGAR2Form 8-K - Current report
31/01/202420:30BWSage Therapeutics to Report Fourth Quarter and Full Year..
25/01/202406:10EDGAR2Form 8-K - Current report
23/01/202422:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
08/01/202420:45EDGAR2Form 8-K - Current report
08/01/202420:32BWSage Therapeutics to Provide Business Updates at 42nd Annual..
08/01/202420:30BWSage Therapeutics Announces Changes to Board of Directors
05/01/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202420:30BWSage Therapeutics to Present at the 42nd Annual J.P. Morgan..
19/12/202322:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
14/12/202320:30BWZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
08/12/202323:00EDGAR2Form SC TO-C - Written communication relating to an issuer..
08/12/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
08/11/202320:30BWSage Therapeutics to Present at Upcoming November Investor..
07/11/202321:39EDGAR2Form 8-K - Current report
07/11/202321:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/11/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202320:46EDGAR2Form 8-K - Current report
07/11/202320:30BWSage Therapeutics Announces Third Quarter 2023 Financial..
24/10/202319:30BWSage Therapeutics to Report Third Quarter 2023 Financial..
18/10/202320:10DJNSage Therapeutics Gets FDA Orphan Designation for SAGE-718..
18/10/202319:30BWSage Therapeutics Announces U.S. Food and Drug..
06/09/202319:30BWSage Therapeutics to Present at Upcoming September Investor..
31/08/202319:45EDGAR2Form 8-K - Current report
31/08/202319:30BWSage Therapeutics Implements Strategic Reorganization to..
11/08/202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202320:51IHMARKETNEWSTuesday’s Wall Street Highlights: Novo Nordisk, RingCentral,..
07/08/202321:18DJNSage Therapeutics Shares Slide Premarket After Zurzuvae MDD..
07/08/202320:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/08/202320:26IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
07/08/202320:23DJNSage Therapeutics Mulls Job, Pipeline Cuts After FDA..
07/08/202319:45EDGAR2Form 8-K - Current report
07/08/202319:30BWSage Therapeutics Announces Second Quarter 2023 Financial..
05/08/202311:45BWSage Therapeutics to Host Business Update Webcast and..
05/08/202311:42BWFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
05/06/202319:30BWSage Therapeutics to Present at the Goldman Sachs 44th..

최근 히스토리

Delayed Upgrade Clock